Molnupiravir vs Alternatives: COVID‑19 Antiviral Comparison
Oct 1 2025
Multiple System Atrophy (MSA-P) is a rare, aggressive neurological disorder with parkinsonian symptoms and severe autonomic failure. Unlike Parkinson’s, it progresses rapidly, responds poorly to treatment, and has a median survival of only 6-10 years.
Oct 1 2025
Apr 5 2026
Feb 17 2026
Jan 26 2026
Jan 28 2026